{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:48:39Z","timestamp":1783648119782,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s11102-024-01432-w","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T07:07:36Z","timestamp":1722496056000},"page":"537-544","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Diagnostic, therapeutic, and prognostic characteristics of patients with acromegaly according to tumor size at diagnosis"],"prefix":"10.1007","volume":"27","author":[{"given":"Leticia Marinho","family":"Del Corso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cleo Otaviano","family":"Mesa Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente Florentino Castaldo","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solena Ziemer Kusma","family":"Fidalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7285-7941","authenticated-orcid":false,"given":"Cesar Luiz","family":"Boguszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,1]]},"reference":[{"key":"1432_CR1","doi-asserted-by":"crossref","unstructured":"Colao A, Grasso LFS, Giustina A, Melmed S, Chanson P, Pereira AM, Pivonello R (2019) Acromegaly. Nat Rev Dis Primers 5(1):20. Erratum in: Nat Rev Dis Primers 2019;5(1):72","DOI":"10.1038\/s41572-019-0071-6"},{"issue":"1","key":"1432_CR2","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1530\/EJE-20-0281","volume":"183","author":"CL Boguszewski","year":"2020","unstructured":"Boguszewski CL (2020) Acromegaly: \u2018You must know it to think of it\u2019. Eur J Endocrinol 183(1):C1\u2013C4","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1432_CR3","doi-asserted-by":"publisher","first-page":"630","DOI":"10.20945\/2359-3997000000193","volume":"63","author":"L Kasuki","year":"2019","unstructured":"Kasuki L, Rocha PDS, Lamback EB, Gadelha MR (2019) Determinants of morbidities and mortality in acromegaly. Arch Endocrinol Metab 63(6):630\u2013637","journal-title":"Arch Endocrinol Metab"},{"issue":"24","key":"1432_CR4","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1056\/NEJMra062453","volume":"355","author":"S Melmed","year":"2006","unstructured":"Melmed S (2006) Medical progress: Acromegaly. N Engl J Med 355(24):2558\u20132573","journal-title":"N Engl J Med"},{"issue":"3","key":"1432_CR5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1530\/eje.1.01863","volume":"152","author":"P Nomikos","year":"2005","unstructured":"Nomikos P, Buchfelder M, Fahlbusch R (2005) The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical \u2018cure\u2019. Eur J Endocrinol 152(3):379\u2013387","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1432_CR6","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1530\/EJE-14-1117","volume":"172","author":"I Shimon","year":"2015","unstructured":"Shimon I, Jallad RS, Fleseriu M, Yedinak CG, Greenman Y, Bronstein MD (2015) Giant GH-secreting pituitary adenomas: management of rare and aggressive pituitary tumors. Eur J Endocrinol 172(6):707\u2013713","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1432_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3340\/jkns.2015.57.1.23","volume":"57","author":"RW Ho","year":"2015","unstructured":"Ho RW, Huang HM, Ho JT (2015) The influence of pituitary adenoma size on vision and visual outcomes after trans-sphenoidal adenectomy: a report of 78 cases. J Korean Neurosurg Soc 57(1):23\u201331","journal-title":"J Korean Neurosurg Soc"},{"issue":"2","key":"1432_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/02688690220131723","volume":"16","author":"J Garibi","year":"2002","unstructured":"Garibi J, Pomposo I, Villar G, Gaztambide S (2002) Giant pituitary adenomas: clinical characteristics and surgical results. Br J Neurosurg 16(2):133\u2013139","journal-title":"Br J Neurosurg"},{"issue":"6","key":"1432_CR9","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1227\/01.NEU.0000255459.14764.BA","volume":"60","author":"P Mortini","year":"2007","unstructured":"Mortini P, Barzaghi R, Losa M, Boari N, Giovanelli M (2007) Surgical treatment of giant pituitary adenomas: strategies and results in a series of 95 consecutive patients. Neurosurgery 60(6):993\u20131002 discussion 1003-4","journal-title":"Neurosurgery"},{"issue":"11","key":"1432_CR10","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1136\/jnnp.42.11.973","volume":"42","author":"L Symon","year":"1979","unstructured":"Symon L, Jakubowski J, Kendall B (1979) Surgical treatment of giant pituitary adenomas. J Neurol Neurosurg Psychiatry 42(11):973\u2013982","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"1432_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3109\/02688690903370305","volume":"24","author":"S Sinha","year":"2010","unstructured":"Sinha S, Sharma BS (2010) Giant pituitary adenomas\u2013an enigma revisited. Microsurgical treatment strategies and outcome in a series of 250 patients. Br J Neurosurg 24(1):31\u201339","journal-title":"Br J Neurosurg"},{"issue":"3","key":"1432_CR12","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s11102-014-0574-9","volume":"18","author":"E Fernandez-Rodriguez","year":"2015","unstructured":"Fernandez-Rodriguez E, Casanueva FF, Bernabeu I (2015) Update on prognostic factors in acromegaly: is a risk score possible? Pituitary 18(3):431\u2013440","journal-title":"Pituitary"},{"issue":"4","key":"1432_CR13","first-page":"765","volume":"18","author":"P Lundin","year":"1997","unstructured":"Lundin P, Ed\u00e9n Engstr\u00f6m B, Karlsson FA, Burman P (1997) Long-term octreotide therapy in growth hormone-secreting pituitary adenomas: evaluation with serial MR. AJNR Am J Neuroradiol 18(4):765\u2013772","journal-title":"AJNR Am J Neuroradiol"},{"issue":"10","key":"1432_CR14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1530\/ERC-17-0253","volume":"24","author":"P Petrossians","year":"2017","unstructured":"Petrossians P, Daly AF, Natchev E, Maione L, Blijdorp K, Sahnoun-Fathallah M, Auriemma R, Diallo AM, Hulting AL, Ferone D, Hana V Jr, Filipponi S, Sievers C, Nogueira C, Fajardo-Monta\u00f1ana C, Carvalho D, Hana V, Stalla GK, Jaffrain-R\u00e9a ML, Delemer B, Colao A, Brue T, Neggers SJCMM, Zacharieva S, Chanson P, Beckers A (2017) Acromegaly at diagnosis in 3173 patients from the Li\u00e8ge Acromegaly Survey (LAS) database. Endocr Relat Cancer 24(10):505\u2013518","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"1432_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1023\/A:1020798430884","volume":"4","author":"M Bondanelli","year":"2001","unstructured":"Bondanelli M, Ambrosio MR, degli Uberti EC (2001) Pathogenesis and prevalence of hypertension in acromegaly. Pituitary 4(4):239\u2013249","journal-title":"Pituitary"},{"issue":"4","key":"1432_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s11102-023-01322-7","volume":"26","author":"TNA Slagboom","year":"2023","unstructured":"Slagboom TNA, van Bunderen CC, De Vries R, Bisschop PH, Drent ML (2023) Prevalence of clinical signs, symptoms and comorbidities at diagnosis of acromegaly: a systematic review in accordance with PRISMA guidelines. Pituitary 26(4):319\u2013332","journal-title":"Pituitary"},{"issue":"6","key":"1432_CR17","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1210\/jc.2018-00325","volume":"103","author":"B Gonz\u00e1lez","year":"2018","unstructured":"Gonz\u00e1lez B, Vargas G, de Los Monteros ALE, Mendoza V, Mercado M (2018) Persistence of diabetes and hypertension after Multimodal Treatment of Acromegaly. J Clin Endocrinol Metab 103(6):2369\u20132375","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1432_CR18","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.1210\/jc.2010-0573","volume":"95","author":"M Puig-Domingo","year":"2010","unstructured":"Puig-Domingo M, Resmini E, Gomez-Anson B, Nicolau J, Mora M, Palomera E, Mart\u00ed C, Halperin I, Webb SM (2010) Magnetic resonance imaging as a predictor of response to somatostatin analogs in acromegaly after surgical failure. J Clin Endocrinol Metab 95(11):4973\u20134978","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1432_CR19","doi-asserted-by":"publisher","first-page":"e532","DOI":"10.1210\/clinem\/dgz187","volume":"105","author":"A Ghajar","year":"2020","unstructured":"Ghajar A, Jones PS, Guarda FJ, Faje A, Tritos NA, Miller KK, Swearingen B, Nachtigall LB (2020) Biochemical control in Acromegaly with Multimodality therapies: outcomes from a Pituitary Center and Changes over Time. J Clin Endocrinol Metab 105(3):e532\u2013e543","journal-title":"J Clin Endocrinol Metab"},{"key":"1432_CR20","doi-asserted-by":"publisher","first-page":"807054","DOI":"10.3389\/fendo.2021.807054","volume":"12","author":"X Guo","year":"2022","unstructured":"Guo X, Zhang R, Zhang D, Wang Z, Gao L, Yao Y, Deng K, Bao X, Feng M, Xu Z, Yang Y, Lian W, Wang R, Ma W, Xing B (2022) Hyperprolactinemia and Hypopituitarism in Acromegaly and Effect of Pituitary surgery: long-term follow-up on 529 patients. Front Endocrinol (Lausanne) 12:807054","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1432_CR21","doi-asserted-by":"publisher","first-page":"1380436","DOI":"10.3389\/fendo.2024.1380436","volume":"15","author":"C Rosendal","year":"2024","unstructured":"Rosendal C, Arlien-S\u00f8borg MC, Nielsen EH, Andersen MS, Feltoft CL, Klose M, Andreassen M, Bruun NH, J\u00f8rgensen JOL, Dal J (2024) Changes in acromegaly comorbidities, treatment, and outcome over three decades: a nationwide cohort study. Front Endocrinol (Lausanne) 15:1380436","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"1432_CR22","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s11102-021-01198-5","volume":"25","author":"M Fleseriu","year":"2022","unstructured":"Fleseriu M, Barkan A, Del Pilar Schneider M, Darhi Y, de Pierrefeu A, Ribeiro-Oliveira A Jr, Petersenn S, Neggers S, Melmed S (2022) Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States. Pituitary 25(2):296\u2013307","journal-title":"Pituitary"},{"issue":"4","key":"1432_CR23","doi-asserted-by":"publisher","first-page":"R121","DOI":"10.1530\/EJE-13-1031","volume":"170","author":"G Raverot","year":"2014","unstructured":"Raverot G, Jouanneau E, Trouillas J (2014) Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies. Eur J Endocrinol 170(4):R121\u2013R132","journal-title":"Eur J Endocrinol"},{"issue":"1\u20132","key":"1432_CR24","doi-asserted-by":"publisher","first-page":"e281","DOI":"10.1016\/j.wneu.2013.08.028","volume":"82","author":"JA Gondim","year":"2014","unstructured":"Gondim JA, Almeida JP, Albuquerque LA, Gomes EF, Schops M (2014) Giant pituitary adenomas: surgical outcomes of 50 cases operated on by the endonasal endoscopic approach. World Neurosurg 82(1\u20132):e281\u2013e290","journal-title":"World Neurosurg"},{"key":"1432_CR25","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.wneu.2018.11.069","volume":"122","author":"F Penner","year":"2019","unstructured":"Penner F, Prencipe N, Pennacchietti V, Pacca P, Cambria V, Garbossa D, Zenga F (2019) Super Giant Growth hormone-secreting Pituitary Adenoma in Young Woman: from ventricles to nose. World Neurosurg 122:544\u2013548","journal-title":"World Neurosurg"},{"key":"1432_CR26","doi-asserted-by":"publisher","first-page":"e1043","DOI":"10.1016\/j.wneu.2021.01.019","volume":"149","author":"T Rahimli","year":"2021","unstructured":"Rahimli T, Hidayetov T, Yusifli Z, Memmedzade H, Rajabov T, Aghayev K (2021) Endoscopic Endonasal Approach to Giant Pituitary adenomas: Surgical outcomes and Review of the literature. World Neurosurg 149:e1043\u2013e1055","journal-title":"World Neurosurg"},{"key":"1432_CR27","doi-asserted-by":"publisher","first-page":"e447","DOI":"10.1016\/j.wneu.2018.03.006","volume":"114","author":"K Elshazly","year":"2018","unstructured":"Elshazly K, Kshettry VR, Farrell CJ, Nyquist G, Rosen M, Evans JJ (2018) Clinical outcomes after endoscopic endonasal resection of Giant Pituitary Adenomas. World Neurosurg 114:e447\u2013e456","journal-title":"World Neurosurg"},{"key":"1432_CR28","doi-asserted-by":"crossref","unstructured":"Trouillas J, Roy P, Sturm N, Dantony E, Cortet-Rudelli C, Viennet G, Bonneville JF, Assaker R, Auger C, Brue T, Cornelius A, Dufour H, Jouanneau E, Fran\u00e7ois P, Galland F, Mougel F, Chapuis F, Villeneuve L, Maurage CA, Figarella-Branger D, Raverot G (2013) members of HYPOPRONOS; Barlier A, Bernier M, Bonnet F, Borson-Chazot F, Brassier G, Caulet-Maugendre S, Chabre O, Chanson P, Cottier JF, Delemer B, Delgrange E, Di Tommaso L, Eimer S, Gaillard S, Jan M, Girard JJ, Lapras V, Loiseau H, Passagia JG, Patey M, Penfornis A, Poirier JY, Perrin G, Tabarin A. A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol 126(1):123\u2009\u2013\u200935","DOI":"10.1007\/s00401-013-1084-y"},{"issue":"5","key":"1432_CR29","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1046\/j.1365-2265.1999.00760.x","volume":"50","author":"S Ahmed","year":"1999","unstructured":"Ahmed S, Elsheikh M, Stratton IM, Page RC, Adams CB, Wass JA (1999) Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience. Clin Endocrinol (Oxf) 50(5):561\u2013567","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"1432_CR30","first-page":"1239","volume":"48","author":"I Shimon","year":"2001","unstructured":"Shimon I, Cohen ZR, Ram Z, Hadani M (2001) Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Neurosurgery 48(6):1239\u20131243 discussion 1244-5","journal-title":"Neurosurgery"},{"issue":"3","key":"1432_CR31","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s12020-022-03241-2","volume":"79","author":"B Koylu","year":"2023","unstructured":"Koylu B, Firlatan B, Sendur SN, Oguz SH, Dagdelen S, Erbas T (2023) Giant growth hormone-secreting pituitary adenomas from the endocrinologist\u2019s perspective. Endocrine 79(3):545\u2013553","journal-title":"Endocrine"},{"issue":"6","key":"1432_CR32","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s11102-023-01356-x","volume":"26","author":"M Chen","year":"2023","unstructured":"Chen M, Duan L, Miao H, Yu N, Yang S, Wang L, Gong F, Yao Y, Zhu H (2023) Clinical characteristics and therapeutic outcomes of acromegalic patients with giant growth hormone-secreting pituitary adenomas: a single-center study of 67 cases. Pituitary 26(6):675\u2013685","journal-title":"Pituitary"},{"issue":"1","key":"1432_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11102-007-0078-y","volume":"12","author":"F Castinetti","year":"2009","unstructured":"Castinetti F, Morange I, Dufour H, Regis J, Brue T (2009) Radiotherapy and radiosurgery in acromegaly. Pituitary 12(1):3\u201310","journal-title":"Pituitary"},{"issue":"4","key":"1432_CR34","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s11154-020-09588-z","volume":"21","author":"A Giustina","year":"2020","unstructured":"Giustina A, Barkhoudarian G, Beckers A, Ben-Shlomo A, Biermasz N, Biller B, Boguszewski C, Bolanowski M, Bollerslev J, Bonert V, Bronstein MD, Buchfelder M, Casanueva F, Chanson P, Clemmons D, Fleseriu M, Formenti AM, Freda P, Gadelha M, Geer E, Gurnell M, Heaney AP, Ho KKY, Ioachimescu AG, Lamberts S, Laws E, Losa M, Maffei P, Mamelak A, Mercado M, Molitch M, Mortini P, Pereira AM, Petersenn S, Post K, Puig-Domingo M, Salvatori R, Samson SL, Shimon I, Strasburger C, Swearingen B, Trainer P, Vance ML, Wass J, Wierman ME, Yuen KCJ, Zatelli MC, Melmed S (2020) Multidisciplinary management of acromegaly: a consensus. Rev Endocr Metab Disord 21(4):667\u2013678","journal-title":"Rev Endocr Metab Disord"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01432-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-024-01432-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01432-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T04:56:09Z","timestamp":1730868969000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-024-01432-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1432"],"URL":"https:\/\/doi.org\/10.1007\/s11102-024-01432-w","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]},"assertion":[{"value":"11 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CLB has received lecture fees and served as a consultant from Ipsen, Recordati, and Novo Nordisk, and has been the principal investigator of clinical trials of Novartis, Crinetics and Recordati. The other authors have nothing to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"CLB has received lecture fees and served as consultant from Ipsen, Recordati, Novo Nordisk, has been principal investigator of clinical trials of Novartis, Crinetics and Recordati. The other authors have nothing to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}